Webinar: Optimizing Screening for MASH Using EHR-Based Care Pathways

Register today!

Join us for an Exclusive Webinar: Optimizing Screening for MASH Using EHR-Based Care Pathways

Petauri Kinect and MASHNET are excited to invite you to an upcoming webinar, “Optimizing Screening for MASH Using EHR-Based Care Pathways.” In this insightful session, Dr. Sujit Janardhan will explore how EHR-based care pathways can be leveraged to enhance screening for MASH. He’ll share key design principles, implementation strategies, and valuable lessons learned throughout the process.

The discussion will delve into:

  • Integrating care pathways into clinical workflows
  • Building robust data infrastructure to support screening
  • Applying implementation science in real-world healthcare settings

This work is supported by Novo Nordisk. It is intended for US audiences.

Event Details

Date: Tuesday, October 28, 2025

Time: 12:00-1:00 PM EST

Location: Online (Zoom)

Please register by Monday, October 27, 2025.

This session is especially relevant for:

  • Leaders with a focus on population health
  • Professionals involved in MASH care delivery
  • Experts in cardiometabolic health
  • Care coordinators
  • Quality improvement specialists
  • Implementation science researchers

You can submit your questions in advance through the Zoom registration form. We also welcome you to share this invitation with interested colleagues.

Featured Speaker

Dr. Sujit Janardhan, MD, PhD
Director of the Weight Intervention in Liver Disease Clinical Program and Co-founder of the Metabolic Health Consortium at Rush University Medical Center, Chicago IL

Dr. Sujit V. Janardhan is a nationally recognized hepatologist and implementation science leader at Rush University Medical Center. He serves as the Director of the Weight Intervention in Liver Disease Clinical Program, and Co-founder of the Metabolic Health Consortium. His clinical and research work focuses on the intersection of liver disease, obesity, and metabolic health, with a particular emphasis on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).